GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins October 09, 2024
Displaying entries 30201 - 30250 of 39437 in total
PDB ID UniProt ID ▼ Title Descriptor
3X2H B3Y002 X-ray structure of PcCel45A N92D with cellopentaose at 95K. Endoglucanase V-like protein
3X2K B3Y002 X-ray structure of PcCel45A D114N with cellopentaose at 95K. Endoglucanase V-like protein
3X2M B3Y002 X-ray structure of PcCel45A with cellopentaose at 0.64 angstrom resolution. Endoglucanase V-like protein
3X2P B3Y002 Neutron and X-ray joint refined structure of PcCel45A with cellopentaose at 298K. Endoglucanase V-like protein
5KJQ B3Y002 X-ray structure of PcCel45A in complex with cellobiose expressed in Aspergillus nidullans
6ZV5 B3VS76 CML1 crystal structure in complex with Lewis a tetrasaccharide
6ZU2 B3VS76 CML1 crystal structure in complex with H-type 1 trisaccharide
4B8V B3VBK9 Cladosporium fulvum LysM effector Ecp6 in complex with a beta-1,4- linked N-acetyl-D-glucosamine tetramer EXTRACELLULAR PROTEIN 6
4B9H B3VBK9 Cladosporium fulvum LysM effector Ecp6 in complex with a beta-1,4- linked N-acetyl-D-glucosamine tetramer: I3C heavy atom derivative EXTRACELLULAR PROTEIN 6
4PN6 B3UWV7 Structure of the Cytomegalovirus-Encoded m04 Glycoprotein
6MDT B3UF58 Crystal structure of the B41 SOSIP.664 Env trimer with PGT124 and 35O22 Fabs, in P63 space group
6MCO B3UF08 Crystal structure of the B41 SOSIP.664 Env trimer with PGT124 and 35O22 Fabs, in P23 space group
6OPO B3UEZ6 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6U59 B3UEZ6 HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B SOSIP.664 gp120, SOSIP.664 gp41, rabbit antibody 13B Fragment antigen binding light chain, rabbit antibody 13B Fragment antigen binding heavy chain
6MUF B3UEZ6 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6OPQ B3UEZ6 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6CH9 B3UEZ6 Crystal structure of a natively-glycosylated B41 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22
6OPN B3UEZ6 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6OPP B3UEZ6 Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM 17b Fab light chain, Envelope glycoprotein gp41, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5B B3UEZ6 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5C B3UEZ6 Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VN3 B3UEZ6 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VN8 B3UEZ6 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
6EDU B3UEZ6 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6OKP B3UEZ6 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6MUG B3UEZ6 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6OPO B3UES2 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6U59 B3UES2 HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B SOSIP.664 gp120, SOSIP.664 gp41, rabbit antibody 13B Fragment antigen binding light chain, rabbit antibody 13B Fragment antigen binding heavy chain
6U59 B3UES2 HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B SOSIP.664 gp120, SOSIP.664 gp41, rabbit antibody 13B Fragment antigen binding light chain, rabbit antibody 13B Fragment antigen binding heavy chain
6MDT B3UES2 Crystal structure of the B41 SOSIP.664 Env trimer with PGT124 and 35O22 Fabs, in P63 space group
6MUF B3UES2 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6OPQ B3UES2 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6CH9 B3UES2 Crystal structure of a natively-glycosylated B41 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22
6OPN B3UES2 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6OPP B3UES2 Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM 17b Fab light chain, Envelope glycoprotein gp41, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5B B3UES2 Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
6X5C B3UES2 Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VN3 B3UES2 Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain
5VN8 B3UES2 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
6EDU B3UES2 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6OKP B3UES2 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6MCO B3UES2 Crystal structure of the B41 SOSIP.664 Env trimer with PGT124 and 35O22 Fabs, in P23 space group
6MUG B3UES2 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
4H04 B3TLD6 Lacto-N-biosidase from Bifidobacterium bifidum Lacto-N-biosidase (E.C.3.2.1.140)
4JAW B3TLD6 Crystal Structure of Lacto-N-Biosidase from Bifidobacterium bifidum complexed with LNB-thiazoline
5BXP B3TLD6 LNBase in complex with LNB-LOGNAc
5BXR B3TLD6 LNBase in complex with LNB-NHAcDNJ
5BXS B3TLD6 LNBase in complex with LNB-NHAcCAS
5BXT B3TLD6 LNBase in complex with LNB-NHAcAUS
5FKS B3PKK9 Unraveling the first step of xyloglucan degradation by the soil saprophyte Cellvibrio japonicus through the functional and structural characterization of a potent GH74 endo-xyloglucanase

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024